WHO Seeks 'Additional Clarifications' From Bharat Biotech For Covaxin To Conduct Final 'Risk-Benefit Assessment'
Bharat Biotech's Covaxin May Get WHO's Approval By End Of September, Says Dr V K Paul
What We Know About Union Health Minister's Meeting With WHO Chief Scientist
Bharat Biotech Denies Reports About Phase 3 Trial Data Submission To WHO
